Tjebbe W Galema, TW Galema gained his medical degree in 1987 from the Free University, Amsterdam, and registered as a cardiologist in 1995. For the past 10 years he has worked at the Thoraxcentre ...

Yescarta – a CD19-directed genetically modified autologous T-cell immunotherapy investigated in the ZUMA-1 trial – is the first chimeric antigen receptor (CAR) T-cell therapy recommended for ...